Librela – Wonderdrug or hidden risk?
Librela (bedinvetmab) is a monoclonal antibody against nerve growth factor licensed for canine osteoarthritis pain – and similarly Solensia in cats. This article reviews the growing pharmacovigilance evidence and positions Librela safely within the OA treatment cascade.
Read more →